[Hair-growth disorders in relation to pregnancy and hormonal contraception].
D000505:Alopecia / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D000726:Androgen Antagonists; D003276:Contraceptives, Oral / Q000009:adverse effects* / Q000627:therapeutic use; D003534:Cyproterone / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006197:Hair / Q000254:growth & development; D006628:Hirsutism / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D009277:Nandrolone / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications
D000726:Androgen Antagonists; D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D009277:Nandrolone; D003534:Cyproterone
Haarwuchsstörungen in Zusammenhang mit Schwangerschaft und hormonaler Kontrazeption.